Grandeur Peak Global Advisors LLC cut its stake in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) by 0.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 561,535 shares of the medical device company's stock after selling 3,047 shares during the period. Grandeur Peak Global Advisors LLC's holdings in Cardiovascular Systems were worth $12,691,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of CSII. Acadian Asset Management LLC grew its stake in shares of Cardiovascular Systems by 294.7% during the 4th quarter. Acadian Asset Management LLC now owns 2,684 shares of the medical device company's stock valued at $50,000 after acquiring an additional 2,004 shares during the period. Signaturefd LLC increased its stake in shares of Cardiovascular Systems by 8,110.3% in the first quarter. Signaturefd LLC now owns 2,381 shares of the medical device company's stock worth $54,000 after purchasing an additional 2,352 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Cardiovascular Systems by 32.1% during the 1st quarter. PNC Financial Services Group Inc. now owns 3,025 shares of the medical device company's stock valued at $68,000 after purchasing an additional 735 shares during the period. Point72 Hong Kong Ltd bought a new position in Cardiovascular Systems in the 4th quarter worth $74,000. Finally, Nisa Investment Advisors LLC boosted its holdings in Cardiovascular Systems by 54.3% in the 1st quarter. Nisa Investment Advisors LLC now owns 3,495 shares of the medical device company's stock worth $79,000 after buying an additional 1,230 shares during the period. Institutional investors own 91.72% of the company's stock.
Get
Cardiovascular Systems alerts:
Cardiovascular Systems Price Performance
NASDAQ:CSII opened at $13.16 on Tuesday. The business's 50-day simple moving average is $15.33 and its two-hundred day simple moving average is $17.50. Cardiovascular Systems, Inc. has a 52 week low of $12.77 and a 52 week high of $36.97. The stock has a market cap of $539.17 million, a PE ratio of -13.79 and a beta of 0.97. The company has a quick ratio of 5.19, a current ratio of 6.05 and a debt-to-equity ratio of 0.08.
Cardiovascular Systems Profile
(Get Rating)
Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
Featured Stories
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- Is Autozone A Buy Before Earnings Are Released?
- Affirm is the Underdog Starring in a Spaghetti Western
- Is There Value in Verizon Shares at These Levels?
- MarketBeat Podcast: Stock Market, Bad News is Good News
- Forget Bitcoin, Block's Ecosystems are the Real Growth Drivers
Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating).
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.
